RICHARD HANSON: Open Payments
NPI 1568412963 · SALT LAKE CITY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$149 in 7 payments from 6 companies in 2025. Trend: 2023 $174 · 2024 $287 · 2025 $149
Food & beverage: $149
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $52 |
| Astellas Pharma US Inc | 1 | $23 |
| Merck Sharp & Dohme LLC | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| SpringWorks Therapeutics, Inc. | 1 | $17 |
| Daiichi Sankyo Inc. | 1 | $15 |
Products named: IMFINZI, Vyloy, KEYTRUDA, ICLUSIG, OGSIVEO, Enhertu.
Industry payments across UT — which companies pay providers there.
